Effect of Calcium-Sulphate-Bicarbonate Water in a Murine Model of Non-Alcoholic Fatty Liver Disease: A Histopathology Study.
Animals
Bicarbonates
/ metabolism
Calcium
/ metabolism
Calcium Sulfate
Choline
/ metabolism
Choline Deficiency
/ complications
Disease Models, Animal
Lipopolysaccharides
/ metabolism
Liver
/ metabolism
Methionine
/ metabolism
Mice
Mice, Inbred C57BL
Mineral Waters
Non-alcoholic Fatty Liver Disease
/ metabolism
Sulfates
/ metabolism
Toll-Like Receptor 4
/ metabolism
inflammation
lipopolysaccharide
lipotoxicity
liver disease
natural mineral water
steatosis
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
received:
29
07
2022
revised:
29
08
2022
accepted:
31
08
2022
entrez:
9
9
2022
pubmed:
10
9
2022
medline:
14
9
2022
Statut:
epublish
Résumé
The progression of nonalcoholic fatty liver disease (NAFLD) is associated with alterations of the gut-liver axis. The activation of toll-like receptor 4 (TLR4) pathways by endotoxins, such as lipopolysaccharide (LPS), contributes to liver injury. The aim of the present study was to evaluate the possible beneficial effects of a calcium-sulphate-bicarbonate natural mineral water on the gut-liver axis by evaluating liver and terminal ileum histopathology in a murine model of NAFLD. NAFLD was induced in mice by administrating a methionine-choline-deficient (MCD) diet. The following experimental groups were evaluated: controls (N = 10); MCD+Tap water (MCD; N = 10); MCD+Calcium-sulphate-bicarbonate water (MCD/W
Identifiants
pubmed: 36077461
pii: ijms231710065
doi: 10.3390/ijms231710065
pmc: PMC9456359
pii:
doi:
Substances chimiques
Bicarbonates
0
Lipopolysaccharides
0
Mineral Waters
0
Sulfates
0
Toll-Like Receptor 4
0
Methionine
AE28F7PNPL
Choline
N91BDP6H0X
Calcium
SY7Q814VUP
Calcium Sulfate
WAT0DDB505
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : FoRST - Fondazione per la Ricerca Scientifica Termale
ID : Code: 1136
Références
Int J Mol Sci. 2020 Apr 23;21(8):
pubmed: 32340286
Diabetes. 2012 Feb;61(2):372-82
pubmed: 22210320
Eur J Nutr. 2017 Mar;56(2):491-499
pubmed: 26582579
Cells. 2020 Mar 02;9(3):
pubmed: 32131439
J Hepatol. 2020 Mar;72(3):558-577
pubmed: 31622696
Antioxidants (Basel). 2021 Nov 05;10(11):
pubmed: 34829645
Int J Mol Sci. 2019 Jan 14;20(2):
pubmed: 30646522
Sci Rep. 2017 Nov 17;7(1):15756
pubmed: 29150621
Arch Biochem Biophys. 2021 Oct 30;711:109019
pubmed: 34478730
Lancet. 2021 Jun 5;397(10290):2212-2224
pubmed: 33894145
J Tradit Complement Med. 2019 Apr 22;10(4):320-326
pubmed: 32695648
Cell Mol Life Sci. 2021 Dec 24;79(1):10
pubmed: 34951664
Horm Mol Biol Clin Investig. 2015 Feb;21(2):149-57
pubmed: 25720087
Front Pharmacol. 2022 Jun 28;13:869446
pubmed: 35837275
Clin Ter. 2014;165(5):e346-52
pubmed: 25366951
Int J Mol Sci. 2020 Jan 04;21(1):
pubmed: 31947992
JAMA. 2020 Mar 24;323(12):1175-1183
pubmed: 32207804
Nat Commun. 2021 May 10;12(1):2587
pubmed: 33972537
Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):349-364
pubmed: 29740166
World J Gastroenterol. 2012 Mar 7;18(9):930-7
pubmed: 22408352
J Hepatol. 2016 Jun;64(6):1388-402
pubmed: 27062661
Nat Med. 2012 Aug;18(8):1279-85
pubmed: 22842477
Gastroenterology. 2022 Jun;162(7):1858-1875.e2
pubmed: 35248539
Eur J Clin Nutr. 2009 Jan;63(1):106-12
pubmed: 17717532
Cell. 2020 Jan 9;180(1):107-121.e17
pubmed: 31866069
Dig Dis Sci. 2017 Sep;62(9):2223-2230
pubmed: 28733867
Hepatology. 2020 Aug;72(2):470-485
pubmed: 31808577
J Pediatr. 2020 Jan;216:117-127.e2
pubmed: 31526528
J Hepatol. 2017 Jun;66(6):1300-1312
pubmed: 28267621
J Hepatol. 2020 Aug;73(2):423-440
pubmed: 32330604
Front Microbiol. 2018 Aug 21;9:1967
pubmed: 30186272
PLoS One. 2014 Dec 23;9(12):e115922
pubmed: 25535951
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13582-7
pubmed: 23898195
J Pediatr. 2018 Mar;194:100-108.e3
pubmed: 29198531
Int J Mol Sci. 2021 Apr 21;22(9):
pubmed: 33919372
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159
pubmed: 30482910
Cell. 2018 Sep 6;174(6):1373-1387.e19
pubmed: 30193111
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78
pubmed: 34707258
Gut. 2019 Feb;68(2):359-370
pubmed: 30171065
Int J Biometeorol. 2020 Jun;64(6):1011-1022
pubmed: 31758319
Hepatology. 2009 Jun;49(6):1877-87
pubmed: 19291785
Clin Cases Miner Bone Metab. 2016 Sep-Dec;13(3):173-180
pubmed: 28228777
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
J Hepatol. 2019 Dec;71(6):1216-1228
pubmed: 31419514